Experts in medicine shortages

AtrimusRx develops innovative solutions that strengthen access to medicines. By combining international pharmaceutical sourcing, pharmaceutical compounding, digital health solutions and regulatory expertise, we help healthcare providers, pharmacies and patients maintain continuity of care when standard treatment options are unavailable.

Founded
2016

Headquarter & production
Stockholn, Sweden

Our Core Operations & Services

Wholesale and community pharmacy

Licenses:
Licensed for wholesale distribution (GDP/WDA), community pharmacy operations, pharmaceutical compounding and handling of controlled medicines.
International sourcing:
Import and distribution of approved medicines from Europe, the United States and other international markets.
Extensive portfolio:
Access to more than 8,000 medicines, strengths and dosage forms that are not always available on the Swedish market.
Nationwide distribution:
Fast and reliable deliveries to community pharmacies, hospital pharmacies and healthcare providers across Sweden.

Digital health solution

Restnoteradelakemedel.se:
National information platform providing real-time information on medicine shortages, treatment alternatives and product availability.
Mobile app:
Mobile application for healthcare professionals supporting the management of medicine shortages and the identification of alternative treatment options.
Named patient portal:
Digital platform for identifying alternative treatment options and facilitating access to unlicensed medicines through Sweden's Named Patient Program.
Procurement portal:
Digital procurement platform for healthcare providers to order approved medicines, compounded medicines and medicines supplied through Sweden's Named Patient Program, with integrated information on medicine shortages and available treatment alternatives.

Personalised compounding – ATRIMUS Px™

Additive manufacturing (3D printing):
Personalised medicines with precise dosing tailored to individual patient needs.
Taste customization:
Medicines can be flavour-adjusted, including vanilla or raspberry for paediatric patients and beef or liver for veterinary applications.
Dynamic dosing:
Multiple patient-specific dose strengths within the same blister pack, enabling simplified dose titration.
Polypills:
Two or more active pharmaceutical ingredients combined into a single dosage form to simplify treatment and improve adherence.

INTERNATIONAL COLLABORATIONS

AtrimusRx is the selected Swedish industry partner in RoboPharma, a strategic European initiative co-funded by the European Union through the EU4Health programme. Together with European authorities, universities and industry partners, we contribute to the development and integration of robotic pharmaceutical manufacturing, AI-driven analytics and automated production workflows.

The objective is to establish flexible, decentralized manufacturing nodes that strengthen Europe's pharmaceutical resilience and preparedness for future crises, pandemics and supply chain disruptions.

Co-funded by the European Union European commission